Twist Bioscience Becomes Digital Preservation Coalition Supporter
February 28 2022 - 8:01AM
Business Wire
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling
customers to succeed through its offering of high-quality synthetic
DNA using its silicon platform, today announced it has become a
part of the Digital Preservation Coalition’s (DPC) Supporter
Program, where members and solution providers can collaborate.
The Digital Preservation Coalition is a membership-based
organization, established in 2002 initially as a collaboration
between a number of agencies operating in the UK and Ireland, now
with global membership. The DPC works to enable its members to
deliver resilient long-term access to digital content and services
to derive enduring value from digital assets and raises awareness
of the strategic, cultural and technological challenges their
members face.
“Our members store immensely rich and valuable cultural and
organizational data, with much of that data archived for a long
period of time,” commented William Kilbride, executive director of
the DPC. “With DNA storage moving from the trial stage to practical
implementation, we believe that it will be valuable for our members
to evaluate this new differentiated storage medium, particularly
with the opportunity to provide input on the initial offering.”
“We are pleased to join the Digital Preservation Coalition and
are eager to be an active member of the group,” said Emily M.
Leproust, Ph.D., CEO and co-founder of Twist. “We look forward to
engaging with members to understand their needs for very long-term
storage as we refine our Century Archive DNA data storage
solution.”
About Twist Bioscience
Twist Bioscience is a leading and rapidly growing synthetic
biology and genomics company that has developed a disruptive DNA
synthesis platform to industrialize the engineering of biology. The
core of the platform is a proprietary technology that pioneers a
new method of manufacturing synthetic DNA by “writing” DNA on a
silicon chip. Twist is leveraging its unique technology to
manufacture a broad range of synthetic DNA-based products,
including synthetic genes, tools for next-generation sequencing
(NGS) preparation, and antibody libraries for drug discovery and
development. Twist is also pursuing longer-term opportunities in
digital data storage in DNA and biologics drug discovery. Twist
makes products for use across many industries including healthcare,
industrial chemicals, agriculture and academic research.
Legal Notice Regarding Forward-Looking Statements
This press release contains forward-looking statements. All
statements other than statements of historical facts contained
herein are forward-looking statements reflecting the current
beliefs and expectations of management made pursuant to the safe
harbor provisions of the Private Securities Litigation Reform Act
of 1995. Forward-looking statements involve known and unknown
risks, uncertainties, and other important factors that may cause
Twist Bioscience’s actual results, performance, or achievements to
be materially different from any future results, performance, or
achievements expressed or implied by the forward-looking
statements. For a description of the risks and uncertainties that
could cause actual results to differ from those expressed in these
forward-looking statements, as well as risks relating to Twist
Bioscience’s business in general, see Twist Bioscience’s risk
factors set forth in Twist Bioscience’s Quarterly Report Form 10-Q
filed with the Securities and Exchange Commission on February 9,
2022 and subsequent filings with the SEC. Any forward-looking
statements contained in this press release speak only as of the
date hereof, and Twist Bioscience specifically disclaims any
obligation to update any forward-looking statement, whether as a
result of new information, future events or otherwise.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220228005319/en/
Angela Bitting SVP, Corporate Affairs Twist Bioscience
abitting@twistbioscience.com
Twist Bioscience (NASDAQ:TWST)
Historical Stock Chart
From Sep 2024 to Oct 2024
Twist Bioscience (NASDAQ:TWST)
Historical Stock Chart
From Oct 2023 to Oct 2024